# ZNF580

## Overview
ZNF580 is a gene that encodes the zinc finger protein 580, a C2H2-type zinc-finger transcription factor. This protein is primarily involved in the regulation of endothelial cell function and vascular homeostasis. It is characterized by its three tandem C2H2 zinc finger domains, which facilitate DNA and protein binding, and a proline-rich N-terminus, aligning it with Sp1-like or Kruppel-like transcription factors (Luo2011ZNF580; Luo2014ZNF580). ZNF580 is ubiquitously expressed across various human tissues, with notable expression in the brain and pancreas, and is predominantly localized in the nuclei of endothelial cells, where it modulates gene expression (Luo2014ZNF580; Sun2010Sphingosine1phosphate). The protein plays a crucial role in the transforming growth factor-beta 1 (TGF-β1) signaling pathway, interacting with Smad2 to influence endothelial nitric oxide synthase (eNOS) expression and other genes involved in vascular physiology (Luo2011ZNF580; Luo2014ZNF580). Through these interactions, ZNF580 contributes to angiogenesis and vascular health, with potential implications in diseases such as atherosclerosis and type 2 diabetes mellitus (Lu2020Identification; Luo2014ZNF580).

## Structure
The ZNF580 gene encodes a C2H2 zinc-finger transcription factor involved in maintaining vascular endothelium homeostasis. The protein structure of ZNF580 includes a highly conserved C-terminus with three tandem repeated C2H2 zinc finger domains and a proline-rich N-terminus, similar to Sp1-like or Kruppel-like transcription factors (Luo2011ZNF580; Luo2014ZNF580). These zinc finger domains are traditionally known for DNA binding but also play a significant role in protein binding (Luo2011ZNF580). ZNF580 is a protein containing 171 or 172 amino acids, depending on the source, and is ubiquitously expressed in human tissues, particularly in the brain and pancreas (Luo2014ZNF580; Sun2010Sphingosine1phosphate).

The protein is mainly localized in the nuclei of certain cell lines, including endothelial cells, suggesting its role in transcriptional regulation (Luo2011ZNF580; Luo2014ZNF580). ZNF580 interacts with Smad2, a TGF-β signal molecule, indicating its involvement in the TGF-β signaling pathway (Luo2011ZNF580). The protein's interaction with Smad2 suggests a potential role in directing Smad2 to specific promoter regions, despite the absence of a Smad-binding element in some promoter regions (Luo2014ZNF580). The specific molecular structure details beyond these domains are not provided in the available context.

## Function
ZNF580 is a C2H2 zinc-finger transcription factor that plays a significant role in endothelial cell function and vascular homeostasis. It is involved in the transforming growth factor-beta 1 (TGF-β1) signaling pathway, where it interacts with Smad2, a key signaling molecule, to regulate endothelial cell migration and proliferation (Luo2011ZNF580; Luo2014ZNF580). ZNF580 enhances the expression of endothelial nitric oxide synthase (eNOS), a crucial enzyme for nitric oxide production, which is vital for vascular physiology and endothelial cell function (Luo2014ZNF580).

In endothelial cells, ZNF580 is primarily localized in the nucleus, where it modulates gene expression, including upregulation of eNOS and other genes involved in cell cycle and signal transduction (Luo2014ZNF580). The protein also influences angiogenesis by regulating the expression of vascular endothelial growth factor (VEGF) and matrix metalloproteinase-2 (MMP-2), which are essential for endothelial cell migration and proliferation (Sun2010Sphingosine1phosphate). Through these molecular activities, ZNF580 contributes to the maintenance of vascular health and may protect against vascular diseases such as atherosclerosis (Luo2014ZNF580).

## Clinical Significance
ZNF580 has been implicated in various diseases and conditions through alterations in its expression levels and interactions. In the context of type 2 diabetes mellitus (T2DM), ZNF580 is identified as a transcription factor involved in the regulatory networks associated with the disease. Although its specific clinical significance in T2DM is not detailed, it is part of a network that modulates the expression of genes related to the disease (Lu2020Identification).

In Leydig cell tumors, ZNF580 is among the upregulated genes associated with biological processes such as response to toxic substances and oxidative stress. However, these upregulated genes, including ZNF580, did not significantly enrich any Gene Ontology category after false discovery rate correction, leaving its precise role in these tumors unclear (Kotula‐Balak2021Transcriptome).

In colon cancer, ZNF580 shows a positive correlation with TGFBI, suggesting its involvement in the regulatory network of colon cancer-related genes. This interaction indicates a potential role in the disease's pathogenesis, although specific clinical implications are not fully elucidated (Du2022Analysis).

Overall, while ZNF580 is associated with several conditions, its exact clinical significance and the impact of its mutations or altered expression require further investigation.

## Interactions
ZNF580, a C2H2 zinc-finger transcription factor, is involved in several protein-protein interactions that influence cellular processes. One significant interaction is with Smad2, a key molecule in the TGF-β signaling pathway. This interaction was confirmed through co-immunoprecipitation assays, indicating a physical association between ZNF580 and Smad2 in HEK-293 cells. Immunofluorescence co-localization assays further demonstrated that ZNF580 and Smad2 predominantly co-localize in the nuclei of EA.hy926 endothelial cells, suggesting a functional interaction in these cells (Luo2011ZNF580).

ZNF580 also plays a role in the regulation of endothelial nitric oxide synthase (eNOS) expression and endothelial cell functions through the TGF-β1/ALK5/Smad2 pathway. Overexpression of ZNF580 enhances eNOS expression, while its downregulation decreases it, indicating that ZNF580 may direct Smad2 to specific regions of the eNOS promoter (Luo2014ZNF580).

In addition to its interaction with Smad2, ZNF580 is involved in the regulation of interleukin-6 (IL-6) production. It acts as a suppressor of IL-6 gene expression, inhibiting LPS-induced IL-6 production in MonoMac6 cells, which suggests that ZNF580 may interact with other transcription factors to exert its inhibitory effects (Stenzel2018ZNF580).


## References


[1. (Kotula‐Balak2021Transcriptome) Malgorzata Kotula‐Balak, Michal Duliban, Artur Gurgul, Izabela Krakowska, Pawel Grzmil, Barbara Bilinska, and Jan Karol Wolski. Transcriptome analysis of human leydig cell tumours reveals potential mechanisms underlying its development. Andrologia, September 2021. URL: http://dx.doi.org/10.1111/and.14222, doi:10.1111/and.14222. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.1111/and.14222)

[2. (Luo2014ZNF580) Yuyu Luo, Ying Zhao, Xiaodong Li, Juan Zhao, and Wencheng Zhang. Znf580 mediates enos expression and endothelial cell migration/proliferation via the tgf-β1/alk5/smad2 pathway. Molecular and Cellular Biochemistry, 393(1–2):199–207, April 2014. URL: http://dx.doi.org/10.1007/s11010-014-2061-z, doi:10.1007/s11010-014-2061-z. This article has 25 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s11010-014-2061-z)

[3. (Sun2010Sphingosine1phosphate) Hui-Yan Sun, Shu-Ping Wei, Rui-Cheng Xu, Peng-Xiao Xu, and Wen-Cheng Zhang. Sphingosine-1-phosphate induces human endothelial vegf and mmp-2 production via transcription factor znf580: novel insights into angiogenesis. Biochemical and Biophysical Research Communications, 395(3):361–366, May 2010. URL: http://dx.doi.org/10.1016/j.bbrc.2010.04.019, doi:10.1016/j.bbrc.2010.04.019. This article has 70 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.bbrc.2010.04.019)

[4. (Lu2020Identification) Yana Lu, Yihang Li, Guang Li, and Haitao Lu. Identification of potential markers for type 2 diabetes mellitus via bioinformatics analysis. Molecular Medicine Reports, 22(3):1868–1882, June 2020. URL: http://dx.doi.org/10.3892/mmr.2020.11281, doi:10.3892/mmr.2020.11281. This article has 28 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/mmr.2020.11281)

[5. (Luo2011ZNF580) Yuyu Luo, Wenliang Hu, Ruicheng Xu, Bing Hou, Lijun Zhang, and Wencheng Zhang. Znf580, a novel c2h2 zinc-finger transcription factor, interacts with the tgf-β signal molecule smad2. Cell Biology International, 35(11):1153–1157, October 2011. URL: http://dx.doi.org/10.1042/CBI20110050, doi:10.1042/cbi20110050. This article has 27 citations and is from a peer-reviewed journal.](https://doi.org/10.1042/CBI20110050)

[6. (Stenzel2018ZNF580) Philipp Stenzel, Kaj Nagorsen, Jonathan Bernd, Ulrike Leppert, Andreas Zakrzewicz, and Janine Berkholz. Znf580 – a brake on interleukin-6. Journal of Inflammation, October 2018. URL: http://dx.doi.org/10.1186/s12950-018-0196-5, doi:10.1186/s12950-018-0196-5. This article has 5 citations.](https://doi.org/10.1186/s12950-018-0196-5)

[7. (Du2022Analysis) Cheng Du, XinLi Liu, Mingwei Li, Yi Zhao, Jie Li, Zhikang Wen, Min Liu, Meina Yang, Boshi Fu, and Minjie Wei. Analysis of 5-methylcytosine regulators and dna methylation-driven genes in colon cancer. Frontiers in Cell and Developmental Biology, January 2022. URL: http://dx.doi.org/10.3389/fcell.2021.657092, doi:10.3389/fcell.2021.657092. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fcell.2021.657092)